BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30417790)

  • 1. Efficacy of β-D-Mannuronic Acid [M2000] on the Pro-Apoptotic Process and Inflammatory-Related Molecules NFκB, IL-8 and Cd49d using Healthy Donor PBMC.
    Khalatbari A; Mahdavi M; Jafarnezhad F; Afraei S; Zavareh FT; Aghazadeh Z; Ghaderi A; Mirshafiey A
    Curr Drug Discov Technol; 2020; 17(2):225-232. PubMed ID: 30417790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of β-D-Mannuronic Acid (M2000) on Oxidative Stress Enzymes' Gene Using Healthy Donor Peripheral Blood Mononuclear Cells for Evaluating the Anti-Aging Property.
    Taeb M; Jafarzadeh A; Mortazavi-Jahromi SS; Zainodini N; Mirzaei MR; Jafarnezhad-Ansariha F; Aghazadeh Z; Mirshafiey A
    Curr Drug Discov Technol; 2019; 16(3):265-271. PubMed ID: 29766814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Oral Administration Effect of Drug Mannuronic Acid (M2000) on Gene Expression of Matrix and Tissue Inhibitor of Metalloproteinases in Rheumatoid Arthritis Patients.
    Gaafar NAG; Aslani M; Aghazadeh Z; Razavi A; Mirshafiey A
    Curr Drug Discov Technol; 2020; 17(5):704-710. PubMed ID: 31250758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vitro assessment for evaluating the efficiency of β-d-mannuronic acid (M2000) in myelodysplastic syndrome.
    Bakhtiari T; Ghaderi A; Safaee Nodehi SR; Aghazadeh Z; Tofighi Zavareh F; Jafarnezhad-Ansariha F; Barati A; Mirshafiey A
    J Cell Physiol; 2019 Aug; 234(8):12971-12977. PubMed ID: 30537258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of β-D-mannuronic Acid, as a New Member of Non-steroidal Anti- Inflammatory Drugs Family, on the Expression Pattern of Chemokines and their Receptors in Rheumatoid Arthritis.
    Aslani M; Ahmadzadeh A; Aghazadeh Z; Zaki-Dizaji M; Sharifi L; Hosseini M; Mirshafiey A
    Curr Drug Discov Technol; 2021; 18(1):65-74. PubMed ID: 31657689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological effects of β-d-mannuronic acid (M2000) on miR-146a, IRAK1, TRAF6 and NF-κB gene expression, as target molecules in inflammatory reactions.
    Mortazavi-Jahromi SS; Jamshidi MM; Farazmand A; Aghazadeh Z; Yousefi M; Mirshafiey A
    Pharmacol Rep; 2017 Jun; 69(3):479-484. PubMed ID: 28324845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating Mannuronic Acid Effect on Gene Expression Profile of Inflammatory Mediators in Rheumatoid Arthritis Patients.
    Omidian S; Aghazadeh Z; Ahmadzadeh A; Aslani M; Hosseini M; Abbasi S; Mirshafiey A
    Iran J Allergy Asthma Immunol; 2022 Feb; 21(1):44-54. PubMed ID: 35524377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of β-d-mannuronic acid, as a novel non-steroidal anti-inflammatory medication within immunosuppressive properties, on
    Barati A; Jamshidi AR; Ahmadi H; Aghazadeh Z; Mirshafiey A
    Drug Des Devel Ther; 2017; 11():1027-1033. PubMed ID: 28408801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of β-D-mannuronic acid (M2000), as a novel NSAID, on COX1 and COX2 activities and gene expression in ankylosing spondylitis patients and the murine monocyte/macrophage, J774 cell line.
    Jafarnezhad-Ansariha F; Yekaninejad MS; Jamshidi AR; Mansouri R; Vojdanian M; Mahmoudi M; Fattahi MJ; Hashemi SN; Rehm BHA; Matsuo H; Esposito E; Cuzzocrea S; Mirshafiey A
    Inflammopharmacology; 2018 Apr; 26(2):375-384. PubMed ID: 28819782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematological Improvement of Patients with Active Rheumatoid Arthritis by β-D-Mannuronic Acid (M2000) as a Novel NSAID with Immunosuppressive Property.
    Ahmadi H; Jamshidi AR; Mahmoudi M; Gharibdoost F; Vojdanian M; Fattahi MJ; Rastkari N; Aghazadeh Z; Mirshafiey A
    Iran J Allergy Asthma Immunol; 2017 Oct; 16(5):433-442. PubMed ID: 29149783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunopharmacological effect of β-d-mannuronic acid (M2000), as a new immunosuppressive drug, on gene expression of miR-155 and its target molecules (SOCS1, SHIP1) in a clinical trial on rheumatoid arthritis patients.
    Mortazavi-Jahromi SS; Aslani M; Omidian S; Ahmadzadeh A; Rezaieyazdi Z; Mirshafiey A
    Drug Dev Res; 2020 May; 81(3):295-304. PubMed ID: 31675124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction of β-d-mannuronic acid (M2000) as a novel NSAID with immunosuppressive property based on COX-1/COX-2 activity and gene expression.
    Mirshafiey A; Taeb M; Mortazavi-Jahromi SS; Jafarnezhad-Ansariha F; Rehm BHA; Esposito E; Cuzzocrea S; Matsuo H
    Pharmacol Rep; 2017 Oct; 69(5):1067-1072. PubMed ID: 28951072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of β-d-mannuronic acid, as a new non-steroidal anti-inflammatory drug on expression of miR-146a, IRAK1, TRAF6, NF-κB and pro-inflammatory cytokines following a clinical trial in rheumatoid arthritis patients.
    Mortazavi-Jahromi SS; Ahmadzadeh A; Rezaieyazdi Z; Aslani M; Omidian S; Mirshafiey A
    Immunopharmacol Immunotoxicol; 2020 Jun; 42(3):228-236. PubMed ID: 32223462
    [No Abstract]   [Full Text] [Related]  

  • 14. The Situation of Chemokine Ligands and Receptors Gene Expression, Following the Oral Administration of Drug Mannuronic Acid in Rheumatoid Arthritis Patients.
    Aslani M; Ahmadzadeh A; Rezaieyazdi Z; Mortazavi-Jahromi SS; Barati A; Hosseini M; Mirshafiey A
    Recent Pat Inflamm Allergy Drug Discov; 2020; 14(1):69-77. PubMed ID: 31729947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-D-mannuronic Acid (M2000) and Inflammatory Cytokines in COVID-19; An In vitro Study.
    Robat-Jazi B; Ghorban K; Gholami M; Samizadeh E; Aghazadeh Z; Shahrbaf MA; Dadmanesh M; Hosseini Rouzbahani N; Mirshafiey A
    Iran J Allergy Asthma Immunol; 2022 Dec; 21(6):677-686. PubMed ID: 36640059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotective effect of β-d-mannuronic acid (M2000) as a novel NSAID on gene expression of oxLDL scavenger receptors in the experimental diabetic model.
    Mortazavi-Jahromi SS; Alizadeh S; Javanbakht MH; Mirshafiey A
    Immunopharmacol Immunotoxicol; 2018 Aug; 40(4):284-289. PubMed ID: 29619884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory effects of M2000 (β-D-Mannuronic acid) on TNF-α, IL-17 and FOXP3 gene expression in patients with inflammatory bowel disease.
    Mohammed HA; Saboor-Yaraghi AA; Vahedi H; Yekaninejad MS; Panahi G; Hemmasi G; Lakzaei M; Mirshafiey A
    Int Immunopharmacol; 2017 Oct; 51():107-113. PubMed ID: 28822915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-diabetic effect of
    Mortazavi-Jahromi SS; Alizadeh S; Javanbakht MH; Mirshafiey A
    Arch Physiol Biochem; 2019 Dec; 125(5):435-440. PubMed ID: 29882437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Anti-Migraine Effects of M2000 (β-D-Mannuronic Acid) on a Patient with Rheumatoid Arthritis: Case Report.
    Vojdanian M; Ahmadi H; Jamshidi AR; Mahmoudi M; Gharibdoost F; Barati A; Mirshafiey A
    Curr Clin Pharmacol; 2017; 12(2):127-130. PubMed ID: 28578645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Biology of β-D-mannuronic acid (M2000) on Human Dendritic Cell Based on MicroRNA-155 and MicroRNA-221.
    Tabrizian N; Fard NA; Farazmand A; Eftekhari R; Zavareh FT; Mirshafiey A
    Curr Drug Discov Technol; 2017; 14(1):53-58. PubMed ID: 27890012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.